Molecular communications in the bloodstream is a promising area of research, since the bloodstream has the ability to ...

A young patient identified by the ELSA study as having early stages of Type 1 Diabetes, has received treatment to delay the ...

For people living with Type 1 Diabetes (T1D), keeping blood sugar levels in check is a constant challenge. A new clinical trial at UVA is aiming to simplify diabetes management by testing an ...

The FDA today issued an alert around a safety concern regarding diabetes devices that rely on smartphones to deliver critical ...

The US FDA warns users of smartphone-linked diabetes devices like CGMs and insulin pumps of potential health risks due to ...

These days, many devices are programmed through apps on patients’ phones. But the FDA warns that certain phone settings, such ...

Eversense 365 is the world’s first and only one year CGM, which was approved by the United States (US) Food and Drug Administration in September of 2024 and launched across the country in October of ...

Dr. Medha N. Munshi, geriatrician and endocrinologist at BIDMC leads research on improving care for older adults with diabetes using digital technologies.

Shanghai's Ruijin Hospital announced today that researchers have developed a groundbreaking non-invasive blood glucose ...

Discover how the first FDA-approved over-the-counter continuous glucose monitor affects the wellness industry and its potential for early diabetes diagnoses.

Of the many health metrics to monitor, blood sugar levels are of great significance, as they can serve as an indicator of overall health. This is especially true for those with diabetes ...